KARISHMA PATEL: Open Payments
NPI 1932897956 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 23 payments from 9 companies in 2025. Trend: 2023 $440 · 2024 $784 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $140 |
| Exact Sciences Corporation | 2 | $133 |
| Dexcom, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Kedrion Biopharma, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Kerendia, BREZTRI, The Cologuard Plus Collection Kit, FARXIGA, AIRSUPRA, Dexcom G6 Transmitter, NEXLETOL, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
